Company
Sania Therapeutics
Precision therapies for prevalent disorders
- Business model
- B2B
- Legal name
- Sania Therapeutics Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Sania [sah-nee-ah] harnesses our nervous system as an access point to treating a broad range of prevalent and underserved disease areas. Our precision therapies combine targeted delivery with a controllable therapeutic to redefine the treatment of nervous system disorders.
Funding snapshot
- Total raised
- $11.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5M2024-05-06
Funding rounds
- Round, 2024
- $5M2024-05-06, SEC form D sold, 4 investors
- Round, 2023
- $1.5M2023-02-21, SEC form D sold, 9 investors
- Round, 2022
- $5M2022-03-18, SEC form D sold, 14 investors
Loading relationship preview